Back to search

Article

An engineered IdeS variant with enhanced activity and performance for IgG degradation

2026-07-01

Abstract excerpt

IgG-degrading enzymes have emerged as innovative therapeutic agents for treating conditions driven by pathogenic antibodies. Here, we used structure-guided rational design to engineer IdeS M33 , a double mutant (K167R/D226E) of the IgG-specific bacterial protease IdeS from Streptococcus pyogenes , with improved catalytic efficiency. Biolayer interferometry revealed a fourfold increase in binding affinity relativ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a6721f15-fdc8-5fee-aa05-49483a1675ae
DOI
10.64898/2026.06.26.734701
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An engineered IdeS variant with enhanced activity and performance for IgG degradationDOI 10.64898/2026.06.26.734701
Select a neighboring publication to make it the new centre.